State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia

Background The incidence of secondary pulmonary infections is not well described in hospitalized COVID-19 patients. Understanding the incidence of secondary pulmonary infections and the associated bacterial and fungal microorganisms identified can improve patient outcomes. Objective This narrative r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection 2021-08, Vol.49 (4), p.591-605
Hauptverfasser:	Chong, Woon H., Saha, Biplab K., Ananthakrishnan Ramani, Chopra, Amit
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - therapeutic use Antibiotics Antiinfectives and antibacterials Antimicrobial Stewardship Bacteria Bacterial diseases Bacterial infections Case reports Coinfection - diagnosis Coinfection - drug therapy Coinfection - epidemiology Coinfection - microbiology Coronaviruses COVID-19 COVID-19 - complications COVID-19 - epidemiology Drug Resistance, Multiple E coli Family Medicine Fungi General Practice Hospitalization Humans Incidence Infections Infectious Diseases Internal Medicine Klebsiella Lung Diseases, Fungal - epidemiology Lung Diseases, Fungal - etiology Lung Diseases, Fungal - microbiology Medicine Medicine & Public Health Microorganisms Multidrug resistance Opportunist infection Pandemics Pneumonia, Bacterial - epidemiology Pneumonia, Bacterial - etiology Pneumonia, Bacterial - microbiology Pseudomonas aeruginosa Public health Respiratory tract Review Risk analysis Risk factors SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 State-of-the-art reviews Time Factors Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!